KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ECYT
Delisted

Endocyte Fund Predictions

$23.99
+0 (+0%)
At Close: Jan 18, 2019
Currently predicting for Mon, 29 Apr 2024

Trading levels for ECYT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.99 .
R2 23.99 .
R1 23.99 .
Current price: 23.99
Support S1 23.99 .
S2 23.99 .
S3 23.99 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 24.00 0.0417 %
Current price 23.99
Support S1 23.85 -0.584%
S2 23.63 -1.50%
S3 23.48 -2.13%

ECYT Predictions History

5 years ago
HoodedMonk predicted that ECYT for 2018-09-28 is going $18.05 (1.63%)

Rank:

5 years ago
HoodedMonk predicted that ECYT for 2018-09-26 is going $18.02 (-1.96%)

Rank:

5 years ago
tallguyaaron predicted that ECYT for 2018-09-26 is going $19.52 (6.20%)

Rank:

5 years ago
JS predicted that ECYT for 2018-05-17 is going $12.88 (-4.66%)

6 years ago
Donald.Wesley.Daughenbaugh.22909 predicted that ECYT for 2018-04-24 is going $2.22 (-75.76%)

Rank:

6 years ago
Josh.Martinez.18950 predicted that ECYT for 2018-04-19 is going $10.58 (9.98%)

Rank:

6 years ago
Fayadosky predicted that ECYT for 2018-03-13 is going $9.27 (4.98%)

Rank:
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT